Propofol for gastrointestinal endoscopy

Toshihiro Nishizawa, Hidekazu Suzuki

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Most gastrointestinal endoscopic procedures are now performed with sedation. Moderate sedation using benzodiazepines and opioids continues to be widely used, but propofol sedation is becoming more popular because its unique pharmacokinetic properties make endoscopy almost painless, with a very predictable and rapid recovery process. There is controversy as to whether propofol should be administered only by anesthesia professionals. According to published values, endoscopist-directed propofol has a lower mortality rate than endoscopist-delivered benzodiazepines and opioids, and a comparable rate to general anesthesia by anesthesiologists. Rapid recovery has a major impact on patient satisfaction, post-procedure education and the general flow of the endoscopy unit. According to estimates, the absolute economic benefit of endoscopist-directed propofol implementation in a screening setting is probably substantial, with 10-year savings of $3.2 billion in the USA. Guidelines concerning the use of propofol emphasize the need for adequate training and certification in sedation by non-anesthetists.

Original languageEnglish
JournalUnited European Gastroenterology Journal
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Gastrointestinal Endoscopy
Propofol
Benzodiazepines
Opioid Analgesics
Endoscopy
Conscious Sedation
Certification
Patient Satisfaction
General Anesthesia
Anesthesia
Pharmacokinetics
Economics
Guidelines
Education
Mortality

Keywords

  • gastrointestinal endoscopy
  • Propofol
  • sedative agents

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Propofol for gastrointestinal endoscopy. / Nishizawa, Toshihiro; Suzuki, Hidekazu.

In: United European Gastroenterology Journal, 01.01.2018.

Research output: Contribution to journalArticle

Nishizawa, Toshihiro ; Suzuki, Hidekazu. / Propofol for gastrointestinal endoscopy. In: United European Gastroenterology Journal. 2018.
@article{8fe72ef988da4110b237a486a2acaf5d,
title = "Propofol for gastrointestinal endoscopy",
abstract = "Most gastrointestinal endoscopic procedures are now performed with sedation. Moderate sedation using benzodiazepines and opioids continues to be widely used, but propofol sedation is becoming more popular because its unique pharmacokinetic properties make endoscopy almost painless, with a very predictable and rapid recovery process. There is controversy as to whether propofol should be administered only by anesthesia professionals. According to published values, endoscopist-directed propofol has a lower mortality rate than endoscopist-delivered benzodiazepines and opioids, and a comparable rate to general anesthesia by anesthesiologists. Rapid recovery has a major impact on patient satisfaction, post-procedure education and the general flow of the endoscopy unit. According to estimates, the absolute economic benefit of endoscopist-directed propofol implementation in a screening setting is probably substantial, with 10-year savings of $3.2 billion in the USA. Guidelines concerning the use of propofol emphasize the need for adequate training and certification in sedation by non-anesthetists.",
keywords = "gastrointestinal endoscopy, Propofol, sedative agents",
author = "Toshihiro Nishizawa and Hidekazu Suzuki",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/2050640618767594",
language = "English",
journal = "United European Gastroenterology Journal",
issn = "2050-6406",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Propofol for gastrointestinal endoscopy

AU - Nishizawa, Toshihiro

AU - Suzuki, Hidekazu

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Most gastrointestinal endoscopic procedures are now performed with sedation. Moderate sedation using benzodiazepines and opioids continues to be widely used, but propofol sedation is becoming more popular because its unique pharmacokinetic properties make endoscopy almost painless, with a very predictable and rapid recovery process. There is controversy as to whether propofol should be administered only by anesthesia professionals. According to published values, endoscopist-directed propofol has a lower mortality rate than endoscopist-delivered benzodiazepines and opioids, and a comparable rate to general anesthesia by anesthesiologists. Rapid recovery has a major impact on patient satisfaction, post-procedure education and the general flow of the endoscopy unit. According to estimates, the absolute economic benefit of endoscopist-directed propofol implementation in a screening setting is probably substantial, with 10-year savings of $3.2 billion in the USA. Guidelines concerning the use of propofol emphasize the need for adequate training and certification in sedation by non-anesthetists.

AB - Most gastrointestinal endoscopic procedures are now performed with sedation. Moderate sedation using benzodiazepines and opioids continues to be widely used, but propofol sedation is becoming more popular because its unique pharmacokinetic properties make endoscopy almost painless, with a very predictable and rapid recovery process. There is controversy as to whether propofol should be administered only by anesthesia professionals. According to published values, endoscopist-directed propofol has a lower mortality rate than endoscopist-delivered benzodiazepines and opioids, and a comparable rate to general anesthesia by anesthesiologists. Rapid recovery has a major impact on patient satisfaction, post-procedure education and the general flow of the endoscopy unit. According to estimates, the absolute economic benefit of endoscopist-directed propofol implementation in a screening setting is probably substantial, with 10-year savings of $3.2 billion in the USA. Guidelines concerning the use of propofol emphasize the need for adequate training and certification in sedation by non-anesthetists.

KW - gastrointestinal endoscopy

KW - Propofol

KW - sedative agents

UR - http://www.scopus.com/inward/record.url?scp=85044570574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044570574&partnerID=8YFLogxK

U2 - 10.1177/2050640618767594

DO - 10.1177/2050640618767594

M3 - Article

JO - United European Gastroenterology Journal

JF - United European Gastroenterology Journal

SN - 2050-6406

ER -